PURPOSE. The role of the polyol pathway metabolism in progressive impairmen
t of retrograde axonal transport was evaluated in the optic nerve of rats w
ith streptozotocin-induced diabetes.
METHODS. Rats with streptozotocin-induced diabetes received a low (3 mg/kg
body weight) or high dose (10 mg/kg body weight) of oral aldose reductase i
nhibitor (ARI). At 1 and 3 months after induction of diabetes, Fluoro-Gold
(FG, Chemicon, Temecula, CA) was injected into the dorsal lateral geniculat
e nucleus. Percentages of FG-labeled large, medium, and small retinal gangl
ion cells (RGCs) per total population were calculated in the retinas of ARI
-treated diabetic, untreated diabetic, and normal control rats.
RESULTS. Mean percentages of FG-labeled large RGCs per total population wer
e significantly decreased in nontreated diabetic rats compared with control
animals at 1 month of induced diabetes. This decrease in FG labeling was n
ot observed in both the low- and high-dose ARI-treated diabetic rats. At 3
months of induced diabetes, FG labeling of both large and medium RGCs was s
ignificantly decreased. This decrease was completely ameliorated by high-do
se ARI treatment.
CONCLUSIONS. These results indicate that diabetes affects retrograde axonal
transport progressively through selective impairment of RGCs and that the
polyol pathway metabolism is involved in such impairment.